Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, Kansas 66047, United States.
Summer Undergraduate Research Program, Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, Kansas 66047, United States.
Mol Pharm. 2024 Aug 5;21(8):4060-4073. doi: 10.1021/acs.molpharmaceut.4c00445. Epub 2024 Jul 16.
Light exposure during manufacturing, storage, and administration can lead to the photodegradation of therapeutic proteins. This photodegradation can be promoted by pharmaceutical buffers or impurities. Our laboratory has previously demonstrated that citrate-Fe(III) complexes generate the CO radical anion when photoirradiated under near UV (λ = 320-400 nm) and visible light (λ = 400-800 nm) [Subelzu, N.; Schöneich, C. 2020, 17 (11), 4163-4179; Zhang, Y. 2022, 19 (11), 4026-4042]. Here, we evaluated the impact of citrate-Fe(III) on the photostability and degradation mechanisms of disulfide-containing proteins (bovine serum albumin (BSA) and NISTmAb) under pharmaceutically relevant conditions. We monitored and localized competitive disulfide reduction and protein oxidation by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) analysis depending on the reaction conditions. These competitive pathways were affected by multiple factors, including light dose, Fe(III) concentration, protein concentration, the presence of oxygen, and light intensity.
在制造、储存和给药过程中的光照会导致治疗性蛋白质发生光降解。这种光降解可能会被药物缓冲剂或杂质所促进。我们实验室之前已经证明,在近紫外光(λ=320-400nm)和可见光(λ=400-800nm)下辐照时,柠檬酸盐-Fe(III)络合物会生成 CO 自由基阴离子[Subelzu, N.; Schöneich, C. 2020, 17 (11), 4163-4179; Zhang, Y. 2022, 19 (11), 4026-4042]。在这里,我们评估了在药物相关条件下,柠檬酸盐-Fe(III)对含二硫键的蛋白质(牛血清白蛋白(BSA)和 NISTmAb)的光稳定性和降解机制的影响。我们通过高效液相色谱-串联质谱(HPLC-MS/MS)分析监测和定位了竞争二硫键还原和蛋白质氧化,具体取决于反应条件。这些竞争途径受到多种因素的影响,包括光剂量、Fe(III)浓度、蛋白质浓度、氧气的存在和光强度。